Clinical Trials Directory

Trials / Completed

CompletedNCT06124131

Building Engagement Using Financial Incentives Trial - Colorectal Cancer Screening

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Tulane University · Academic / Other
Sex
All
Age
45 Years – 75 Years
Healthy volunteers
Accepted

Summary

The goal of this pilot clinical trial is to determine feasibility and explore whether financial incentives paid to primary care patients for completing colorectal cancer screening increase completion of colorectal cancer screening. The main questions it aims to answer are: * Do patient financial incentives for completing colorectal cancer screening increase screening completion? * Does a patient financial incentive for colorectal cancer screening offered alongside patient financial incentives for COVID-19 and flu shots increase completion of those shots? Participants who are due for colorectal cancer screening will receive telephone outreach from primary care staff who will offer a stool-based colorectal cancer screening. Participants will be randomly assigned to either Group 1 or Group 2. Group 1 participants will be offered financial incentives for completing COVID-19 and flu shots within 2 months of enrollment. Group 2 participants will be offered financial incentives for completing a COVID-19 shot, a flu shot, and colorectal cancer screening within 2 months of enrollment. Researchers will compare to see if completion of a COVID-19 shot, a flu shot, and colorectal cancer screening is different between the two groups.

Conditions

Interventions

TypeNameDescription
BEHAVIORALFinancial incentive for colorectal cancer screening$50 incentive paid to participant for completion of colorectal cancer screening within 2 months of enrollment
BEHAVIORALFinancial incentive for flu shot$50 incentive paid to participant for completion of flu shot within 2 months of enrollment
BEHAVIORALFinancial incentive for COVID-19 shot$50 incentive paid to participant for completion of COVID-19 shot within 2 months of enrollment

Timeline

Start date
2023-11-11
Primary completion
2024-03-25
Completion
2024-03-25
First posted
2023-11-09
Last updated
2025-05-04
Results posted
2025-05-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06124131. Inclusion in this directory is not an endorsement.